PDB Short entry for 1HVY HEADER TRANSFERASE 08-JAN-01 1HVY TITLE HUMAN THYMIDYLATE SYNTHASE COMPLEXED WITH DUMP AND RALTITREXED, AN TITLE 2 ANTIFOLATE DRUG, IS IN THE CLOSED CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: RESIDUES 26-313; COMPND 5 EC: 2.1.1.45; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TX61 KEYWDS TOMUDEX, RALTITREXED, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.PHAN,S.KOLI,W.MINOR,R.B.DUNLAP,S.H.BERGER,L.LEBIODA REVDAT 6 13-APR-22 1HVY 1 AUTHOR JRNL REMARK SEQADV REVDAT 6 2 1 LINK REVDAT 5 04-OCT-17 1HVY 1 REMARK REVDAT 4 10-OCT-12 1HVY 1 HETSYN VERSN REVDAT 3 24-FEB-09 1HVY 1 VERSN REVDAT 2 17-MAY-05 1HVY 1 JRNL REMARK REVDAT 1 31-JAN-01 1HVY 0 JRNL AUTH J.PHAN,S.KOLI,W.MINOR,R.B.DUNLAP,S.H.BERGER,L.LEBIODA JRNL TITL HUMAN THYMIDYLATE SYNTHASE IS IN THE CLOSED CONFORMATION JRNL TITL 2 WHEN COMPLEXED WITH DUMP AND RALTITREXED, AN ANTIFOLATE DRUG JRNL REF BIOCHEMISTRY V. 40 1897 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11329255 JRNL DOI 10.1021/BI002413I REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.09 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1463303.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 79.2 REMARK 3 NUMBER OF REFLECTIONS : 78861 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.100 REMARK 3 FREE R VALUE TEST SET COUNT : 5566 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 55.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8562 REMARK 3 BIN R VALUE (WORKING SET) : 0.2330 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 589 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 224 REMARK 3 SOLVENT ATOMS : 596 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.560 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.710 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 38.58 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : DUMPZD1694BME.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : DUMPZD1694BME.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-01. REMARK 100 THE DEPOSITION ID IS D_1000012616. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-98 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89364 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 6.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.96 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, EDTA, TRIS BUFFER, AMMONIUM REMARK 280 SULFATE , PH 8.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 127 CD GLU A 127 OE2 0.078 REMARK 500 GLU B 127 CD GLU B 127 OE2 0.078 REMARK 500 GLU C 127 CD GLU C 127 OE2 0.079 REMARK 500 GLU D 127 CD GLU D 127 OE2 0.080 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 80 70.82 -69.96 REMARK 500 HIS A 141 33.34 -140.29 REMARK 500 ARG A 147 -80.79 -105.73 REMARK 500 PRO A 188 6.67 -64.00 REMARK 500 LEU A 221 -76.06 -94.73 REMARK 500 PRO B 72 59.72 -67.01 REMARK 500 PHE B 80 75.36 -64.19 REMARK 500 PHE B 123 56.02 -106.66 REMARK 500 TYR B 135 -77.48 -13.45 REMARK 500 ARG B 147 -78.43 -111.90 REMARK 500 LEU B 192 107.68 -176.87 REMARK 500 SER B 206 13.76 56.81 REMARK 500 LEU B 221 -74.81 -113.62 REMARK 500 PRO C 133 68.16 -67.84 REMARK 500 HIS C 141 39.75 -141.79 REMARK 500 ARG C 147 -78.87 -106.23 REMARK 500 LEU C 192 116.11 -161.24 REMARK 500 LEU C 221 -69.51 -99.05 REMARK 500 PRO C 275 132.85 -38.62 REMARK 500 PRO C 305 153.77 -49.23 REMARK 500 LYS D 47 114.41 -161.02 REMARK 500 PRO D 72 62.05 -66.42 REMARK 500 PHE D 80 74.24 -66.03 REMARK 500 PHE D 123 48.42 -102.75 REMARK 500 TYR D 135 -71.69 -24.61 REMARK 500 HIS D 141 38.10 -141.38 REMARK 500 ARG D 147 -85.22 -110.20 REMARK 500 LEU D 192 116.56 -161.42 REMARK 500 SER D 206 19.60 58.60 REMARK 500 LEU D 221 -78.54 -96.51 REMARK 500 PRO D 275 133.20 -36.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D16 A 414 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D16 B 415 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D16 C 416 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D16 D 417 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP A 314 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP B 315 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP C 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP D 317 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME A 1514 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME B 1515 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME C 1516 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BME D 1517 DBREF 1HVY A 26 313 UNP P04818 TYSY_HUMAN 25 312 DBREF 1HVY B 26 313 UNP P04818 TYSY_HUMAN 25 312 DBREF 1HVY C 26 313 UNP P04818 TYSY_HUMAN 25 312 DBREF 1HVY D 26 313 UNP P04818 TYSY_HUMAN 25 312 SEQADV 1HVY CME A 43 UNP P04818 CYS 42 MODIFIED RESIDUE SEQADV 1HVY CME B 43 UNP P04818 CYS 42 MODIFIED RESIDUE SEQADV 1HVY CME C 43 UNP P04818 CYS 42 MODIFIED RESIDUE SEQADV 1HVY CME D 43 UNP P04818 CYS 42 MODIFIED RESIDUE SEQRES 1 A 288 PRO PRO HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN SEQRES 2 A 288 HIS ILE LEU ARG CME GLY VAL ARG LYS ASP ASP ARG THR SEQRES 3 A 288 GLY THR GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG SEQRES 4 A 288 TYR SER LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS SEQRES 5 A 288 ARG VAL PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP SEQRES 6 A 288 PHE ILE LYS GLY SER THR ASN ALA LYS GLU LEU SER SER SEQRES 7 A 288 LYS GLY VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP SEQRES 8 A 288 PHE LEU ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY SEQRES 9 A 288 ASP LEU GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE SEQRES 10 A 288 GLY ALA GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY SEQRES 11 A 288 GLN GLY VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE SEQRES 12 A 288 LYS THR ASN PRO ASP ASP ARG ARG ILE ILE MET CYS ALA SEQRES 13 A 288 TRP ASN PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO SEQRES 14 A 288 CYS HIS ALA LEU CYS GLN PHE TYR VAL VAL ASN SER GLU SEQRES 15 A 288 LEU SER CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY SEQRES 16 A 288 LEU GLY VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU SEQRES 17 A 288 THR TYR MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY SEQRES 18 A 288 ASP PHE ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU SEQRES 19 A 288 ASN HIS ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU SEQRES 20 A 288 PRO ARG PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL SEQRES 21 A 288 GLU LYS ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE SEQRES 22 A 288 GLU GLY TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET SEQRES 23 A 288 ALA VAL SEQRES 1 B 288 PRO PRO HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN SEQRES 2 B 288 HIS ILE LEU ARG CME GLY VAL ARG LYS ASP ASP ARG THR SEQRES 3 B 288 GLY THR GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG SEQRES 4 B 288 TYR SER LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS SEQRES 5 B 288 ARG VAL PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP SEQRES 6 B 288 PHE ILE LYS GLY SER THR ASN ALA LYS GLU LEU SER SER SEQRES 7 B 288 LYS GLY VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP SEQRES 8 B 288 PHE LEU ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY SEQRES 9 B 288 ASP LEU GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE SEQRES 10 B 288 GLY ALA GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY SEQRES 11 B 288 GLN GLY VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE SEQRES 12 B 288 LYS THR ASN PRO ASP ASP ARG ARG ILE ILE MET CYS ALA SEQRES 13 B 288 TRP ASN PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO SEQRES 14 B 288 CYS HIS ALA LEU CYS GLN PHE TYR VAL VAL ASN SER GLU SEQRES 15 B 288 LEU SER CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY SEQRES 16 B 288 LEU GLY VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU SEQRES 17 B 288 THR TYR MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY SEQRES 18 B 288 ASP PHE ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU SEQRES 19 B 288 ASN HIS ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU SEQRES 20 B 288 PRO ARG PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL SEQRES 21 B 288 GLU LYS ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE SEQRES 22 B 288 GLU GLY TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET SEQRES 23 B 288 ALA VAL SEQRES 1 C 288 PRO PRO HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN SEQRES 2 C 288 HIS ILE LEU ARG CME GLY VAL ARG LYS ASP ASP ARG THR SEQRES 3 C 288 GLY THR GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG SEQRES 4 C 288 TYR SER LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS SEQRES 5 C 288 ARG VAL PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP SEQRES 6 C 288 PHE ILE LYS GLY SER THR ASN ALA LYS GLU LEU SER SER SEQRES 7 C 288 LYS GLY VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP SEQRES 8 C 288 PHE LEU ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY SEQRES 9 C 288 ASP LEU GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE SEQRES 10 C 288 GLY ALA GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY SEQRES 11 C 288 GLN GLY VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE SEQRES 12 C 288 LYS THR ASN PRO ASP ASP ARG ARG ILE ILE MET CYS ALA SEQRES 13 C 288 TRP ASN PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO SEQRES 14 C 288 CYS HIS ALA LEU CYS GLN PHE TYR VAL VAL ASN SER GLU SEQRES 15 C 288 LEU SER CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY SEQRES 16 C 288 LEU GLY VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU SEQRES 17 C 288 THR TYR MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY SEQRES 18 C 288 ASP PHE ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU SEQRES 19 C 288 ASN HIS ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU SEQRES 20 C 288 PRO ARG PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL SEQRES 21 C 288 GLU LYS ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE SEQRES 22 C 288 GLU GLY TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET SEQRES 23 C 288 ALA VAL SEQRES 1 D 288 PRO PRO HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN SEQRES 2 D 288 HIS ILE LEU ARG CME GLY VAL ARG LYS ASP ASP ARG THR SEQRES 3 D 288 GLY THR GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG SEQRES 4 D 288 TYR SER LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS SEQRES 5 D 288 ARG VAL PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP SEQRES 6 D 288 PHE ILE LYS GLY SER THR ASN ALA LYS GLU LEU SER SER SEQRES 7 D 288 LYS GLY VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP SEQRES 8 D 288 PHE LEU ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY SEQRES 9 D 288 ASP LEU GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE SEQRES 10 D 288 GLY ALA GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY SEQRES 11 D 288 GLN GLY VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE SEQRES 12 D 288 LYS THR ASN PRO ASP ASP ARG ARG ILE ILE MET CYS ALA SEQRES 13 D 288 TRP ASN PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO SEQRES 14 D 288 CYS HIS ALA LEU CYS GLN PHE TYR VAL VAL ASN SER GLU SEQRES 15 D 288 LEU SER CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY SEQRES 16 D 288 LEU GLY VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU SEQRES 17 D 288 THR TYR MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY SEQRES 18 D 288 ASP PHE ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU SEQRES 19 D 288 ASN HIS ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU SEQRES 20 D 288 PRO ARG PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL SEQRES 21 D 288 GLU LYS ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE SEQRES 22 D 288 GLU GLY TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET SEQRES 23 D 288 ALA VAL MODRES 1HVY CME A 43 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1HVY CME B 43 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1HVY CME C 43 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1HVY CME D 43 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 43 10 HET CME B 43 10 HET CME C 43 10 HET CME D 43 10 HET D16 A 414 32 HET UMP A 314 20 HET BME A1514 4 HET D16 B 415 32 HET UMP B 315 20 HET BME B1515 4 HET D16 C 416 32 HET UMP C 316 20 HET BME C1516 4 HET D16 D 417 32 HET UMP D 317 20 HET BME D1517 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM D16 TOMUDEX HETNAM UMP 2'-DEOXYURIDINE 5'-MONOPHOSPHATE HETNAM BME BETA-MERCAPTOETHANOL HETSYN D16 ZD1694; RALTITREXED HETSYN UMP DUMP FORMUL 1 CME 4(C5 H11 N O3 S2) FORMUL 5 D16 4(C21 H22 N4 O6 S) FORMUL 6 UMP 4(C9 H13 N2 O8 P) FORMUL 7 BME 4(C2 H6 O S) FORMUL 17 HOH *596(H2 O) HELIX 1 1 GLY A 29 ARG A 42 1 14 HELIX 2 2 PHE A 80 LYS A 93 1 14 HELIX 3 3 ASN A 97 SER A 103 1 7 HELIX 4 4 ASP A 110 GLY A 113 5 4 HELIX 5 5 SER A 114 LEU A 121 1 8 HELIX 6 6 VAL A 134 PHE A 142 1 9 HELIX 7 7 ASP A 159 ASN A 171 1 13 HELIX 8 8 ASP A 186 MET A 190 5 5 HELIX 9 9 LEU A 221 THR A 241 1 21 HELIX 10 10 HIS A 261 GLN A 270 1 10 HELIX 11 11 LYS A 287 PHE A 291 5 5 HELIX 12 12 LYS A 292 GLU A 294 5 3 HELIX 13 13 GLY B 29 ARG B 42 1 14 HELIX 14 14 PHE B 80 GLY B 94 1 15 HELIX 15 15 ASN B 97 SER B 103 1 7 HELIX 16 16 ASP B 110 GLY B 113 5 4 HELIX 17 17 SER B 114 SER B 120 1 7 HELIX 18 18 VAL B 134 PHE B 142 1 9 HELIX 19 19 ASP B 159 ASN B 171 1 13 HELIX 20 20 ASP B 186 MET B 190 5 5 HELIX 21 21 LEU B 221 GLY B 242 1 22 HELIX 22 22 HIS B 261 GLN B 270 1 10 HELIX 23 23 LYS B 287 PHE B 291 5 5 HELIX 24 24 LYS B 292 GLU B 294 5 3 HELIX 25 25 GLY C 29 ARG C 42 1 14 HELIX 26 26 PHE C 80 LYS C 93 1 14 HELIX 27 27 ASN C 97 SER C 103 1 7 HELIX 28 28 ASP C 110 GLY C 113 5 4 HELIX 29 29 SER C 114 SER C 120 1 7 HELIX 30 30 VAL C 134 PHE C 142 1 9 HELIX 31 31 ASP C 159 ASN C 171 1 13 HELIX 32 32 ASP C 186 MET C 190 5 5 HELIX 33 33 LEU C 221 THR C 241 1 21 HELIX 34 34 HIS C 261 LEU C 269 1 9 HELIX 35 35 LYS C 287 PHE C 291 5 5 HELIX 36 36 LYS C 292 GLU C 294 5 3 HELIX 37 37 GLY D 29 ARG D 42 1 14 HELIX 38 38 PHE D 80 LYS D 93 1 14 HELIX 39 39 ASN D 97 SER D 103 1 7 HELIX 40 40 TRP D 109 SER D 114 1 6 HELIX 41 41 SER D 114 SER D 120 1 7 HELIX 42 42 VAL D 134 PHE D 142 1 9 HELIX 43 43 ASP D 159 ASN D 171 1 13 HELIX 44 44 ASP D 186 MET D 190 5 5 HELIX 45 45 LEU D 221 GLY D 242 1 22 HELIX 46 46 HIS D 261 LEU D 269 1 9 HELIX 47 47 LYS D 287 PHE D 291 5 5 HELIX 48 48 LYS D 292 GLU D 294 5 3 SHEET 1 A 6 VAL A 45 LYS A 47 0 SHEET 2 A 6 THR A 55 SER A 66 -1 O THR A 55 N LYS A 47 SHEET 3 A 6 LYS A 244 TYR A 258 -1 O PHE A 248 N TYR A 65 SHEET 4 A 6 GLU A 207 ASP A 218 1 O LEU A 208 N GLY A 246 SHEET 5 A 6 HIS A 196 VAL A 204 -1 N ALA A 197 O TYR A 213 SHEET 6 A 6 ILE A 178 CYS A 180 -1 N MET A 179 O CYS A 199 SHEET 1 B 2 LYS A 278 ILE A 281 0 SHEET 2 B 2 PHE A 296 GLU A 299 -1 O GLN A 297 N ARG A 280 SHEET 1 C 6 VAL B 45 LYS B 47 0 SHEET 2 C 6 THR B 55 SER B 66 -1 O THR B 55 N LYS B 47 SHEET 3 C 6 LYS B 244 TYR B 258 -1 O PHE B 248 N TYR B 65 SHEET 4 C 6 GLU B 207 ASP B 218 1 O LEU B 208 N GLY B 246 SHEET 5 C 6 HIS B 196 VAL B 204 -1 N ALA B 197 O TYR B 213 SHEET 6 C 6 ILE B 178 CYS B 180 -1 N MET B 179 O CYS B 199 SHEET 1 D 2 LYS B 278 ILE B 281 0 SHEET 2 D 2 PHE B 296 GLU B 299 -1 O GLN B 297 N ARG B 280 SHEET 1 E 6 VAL C 45 LYS C 47 0 SHEET 2 E 6 THR C 55 SER C 66 -1 O THR C 55 N LYS C 47 SHEET 3 E 6 LYS C 244 TYR C 258 -1 O PHE C 248 N TYR C 65 SHEET 4 E 6 GLU C 207 ASP C 218 1 O LEU C 208 N GLY C 246 SHEET 5 E 6 HIS C 196 VAL C 204 -1 N ALA C 197 O TYR C 213 SHEET 6 E 6 ILE C 178 CYS C 180 -1 N MET C 179 O CYS C 199 SHEET 1 F 2 LYS C 278 ILE C 281 0 SHEET 2 F 2 PHE C 296 GLU C 299 -1 O GLN C 297 N ARG C 280 SHEET 1 G 6 VAL D 45 LYS D 47 0 SHEET 2 G 6 THR D 55 SER D 66 -1 O THR D 55 N LYS D 47 SHEET 3 G 6 LYS D 244 TYR D 258 -1 O PHE D 248 N TYR D 65 SHEET 4 G 6 GLU D 207 ASP D 218 1 O LEU D 208 N GLY D 246 SHEET 5 G 6 HIS D 196 VAL D 204 -1 N ALA D 197 O TYR D 213 SHEET 6 G 6 ILE D 178 CYS D 180 -1 N MET D 179 O CYS D 199 SHEET 1 H 2 LYS D 278 ILE D 281 0 SHEET 2 H 2 PHE D 296 GLU D 299 -1 O GLN D 297 N ARG D 280 LINK C ARG A 42 N CME A 43 1555 1555 1.33 LINK C CME A 43 N GLY A 44 1555 1555 1.33 LINK SG CYS A 195 C6 UMP A 314 1555 1555 1.84 LINK C ARG B 42 N CME B 43 1555 1555 1.33 LINK C CME B 43 N GLY B 44 1555 1555 1.33 LINK SG CYS B 195 C6 UMP B 315 1555 1555 1.83 LINK C ARG C 42 N CME C 43 1555 1555 1.33 LINK C CME C 43 N GLY C 44 1555 1555 1.33 LINK SG CYS C 195 C6 UMP C 316 1555 1555 1.84 LINK C ARG D 42 N CME D 43 1555 1555 1.33 LINK C CME D 43 N GLY D 44 1555 1555 1.33 LINK SG CYS D 195 C6 UMP D 317 1555 1555 1.82 SITE 1 AC1 18 PHE A 80 GLU A 87 ILE A 108 TRP A 109 SITE 2 AC1 18 ASP A 218 LEU A 221 GLY A 222 PHE A 225 SITE 3 AC1 18 TYR A 258 MET A 311 ALA A 312 UMP A 314 SITE 4 AC1 18 HOH A 435 HOH A 477 HOH A 548 HOH A 980 SITE 5 AC1 18 HOH A 985 HOH A1017 SITE 1 AC2 16 GLU B 87 ILE B 108 TRP B 109 ASN B 112 SITE 2 AC2 16 ASP B 218 LEU B 221 GLY B 222 PHE B 225 SITE 3 AC2 16 TYR B 258 LYS B 308 MET B 311 ALA B 312 SITE 4 AC2 16 UMP B 315 HOH B 589 HOH B 648 HOH B 789 SITE 1 AC3 15 PHE C 80 GLU C 87 ILE C 108 TRP C 109 SITE 2 AC3 15 ASP C 218 LEU C 221 GLY C 222 PHE C 225 SITE 3 AC3 15 TYR C 258 MET C 311 UMP C 316 HOH C 586 SITE 4 AC3 15 HOH C 605 HOH C 690 HOH C 848 SITE 1 AC4 18 PHE D 80 GLU D 87 ILE D 108 TRP D 109 SITE 2 AC4 18 ASN D 112 ASP D 218 LEU D 221 GLY D 222 SITE 3 AC4 18 PHE D 225 TYR D 258 MET D 311 ALA D 312 SITE 4 AC4 18 UMP D 317 HOH D 604 HOH D 624 HOH D 678 SITE 5 AC4 18 HOH D 865 HOH D 907 SITE 1 AC5 16 ARG A 50 LEU A 192 CYS A 195 HIS A 196 SITE 2 AC5 16 GLN A 214 ARG A 215 SER A 216 GLY A 217 SITE 3 AC5 16 ASP A 218 ASN A 226 HIS A 256 TYR A 258 SITE 4 AC5 16 D16 A 414 HOH A 485 ARG B 175 ARG B 176 SITE 1 AC6 18 ARG A 175 ARG A 176 ARG B 50 LEU B 192 SITE 2 AC6 18 CYS B 195 HIS B 196 GLN B 214 ARG B 215 SITE 3 AC6 18 SER B 216 GLY B 217 ASP B 218 ASN B 226 SITE 4 AC6 18 HIS B 256 TYR B 258 D16 B 415 HOH B 496 SITE 5 AC6 18 HOH B 504 HOH B 565 SITE 1 AC7 15 ARG C 50 CYS C 195 HIS C 196 GLN C 214 SITE 2 AC7 15 ARG C 215 SER C 216 GLY C 217 ASP C 218 SITE 3 AC7 15 ASN C 226 HIS C 256 TYR C 258 D16 C 416 SITE 4 AC7 15 HOH C 672 ARG D 175 ARG D 176 SITE 1 AC8 17 ARG C 175 ARG C 176 ARG D 50 TYR D 135 SITE 2 AC8 17 CYS D 195 HIS D 196 GLN D 214 ARG D 215 SITE 3 AC8 17 SER D 216 GLY D 217 ASP D 218 ASN D 226 SITE 4 AC8 17 HIS D 256 TYR D 258 D16 D 417 HOH D 524 SITE 5 AC8 17 HOH D 619 SITE 1 AC9 7 ARG A 163 VAL A 164 THR A 167 ARG A 176 SITE 2 AC9 7 ILE A 178 HOH A 641 HOH A 997 SITE 1 BC1 5 ARG B 163 THR B 167 ASP B 174 ARG B 176 SITE 2 BC1 5 ILE B 178 SITE 1 BC2 4 ARG C 163 THR C 167 ILE C 178 HOH C 476 SITE 1 BC3 5 ARG D 163 THR D 167 ASP D 174 ARG D 176 SITE 2 BC3 5 ILE D 178 CRYST1 68.849 70.495 74.533 70.23 83.29 73.28 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014525 -0.004363 -0.000330 0.00000 SCALE2 0.000000 0.014812 -0.005007 0.00000 SCALE3 0.000000 0.000000 0.014261 0.00000